Cerebrovascular Dysregulation in Chronic Kidney Disease
NCT ID: NCT05571605
Last Updated: 2025-07-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2022-08-01
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise and Vascular Function in Chronic Kidney Disease
NCT02050035
Exploring the Effects of Exercise Combined With BFRT on Healthy and Patients With CKD
NCT07288905
Exercise as an Adjunct Therapy to Reduce Blood Pressure in Chronic Kidney Disease
NCT02112825
Resistance Exercise Training in Chronic Kidney Disease
NCT03120416
Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients
NCT01399489
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise Training
Participants will exercise 3 times a week on a stationary bicycle. Exercise intensity will begin at low levels (50% of maximal heart rate reserve) and increase as tolerated to a maximum of 80% of maximal heart rate reserve. Exercise time will progress from an initial 20 minutes per session to a maximum of 45 minutes per session.
Exercise
Participants randomized to this arm will exercise on a stationary bicycle.
Stretching
Participants will undergo progressive whole body stretching and balance exercises. This type of low intensity exercise is designed not to increase heart rate but rather to improve joint mobility and the ability to perform activities of daily living. This will serve as the control group to the exercise group. The control group will come in for stretching sessions 3 times per week for 20-45 minutes.
Stretching
Participants randomized to this arm will perform stretching and balance exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
Participants randomized to this arm will exercise on a stationary bicycle.
Stretching
Participants randomized to this arm will perform stretching and balance exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Chronic obstructive pulmonary disease
* Uncontrolled hypertension or hypotension
* Pregnancy or plans to become pregnant
* Inability to exercise on a stationary bicycle
* Current participation in exercise more than 20 minutes twice per week
30 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of North Texas, Denton, TX
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Justin Sprick
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Texas
Denton, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB # 22-305
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.